Arena Pharmaceuticals Inc. shares rose in the extended session Monday following an announcement by the company its chief executive was retiring. Arena shares advanced 5.1% to $2.26. The drug developer said co-founder Jack Lief was retiring as president and CEO, and that Harry Hixson will serve as interim CEO. Arena said it will initiate a search for a new CEO immediately.
Copyright © 2015 MarketWatch, Inc.
Continue Reading Below